CRWV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CRWV is not a good buy right now for a Beginner with a long-term focus, despite the stock being near a major support area and having strong bullish analyst upside targets. The current setup is mixed: the recent Meta-related selloff has hurt sentiment, technical momentum is weak, and the stock is still below key resistance with no proprietary buy signal. For an impatient investor, I would not buy it now; the better call is to wait for clearer price stabilization and confirmation of renewed strength.
The technical trend is bearish to weakly neutral in the short term. MACD histogram is -2.424 and still expanding negatively, which signals downside momentum. RSI_6 at 20.859 indicates the stock is oversold, but not yet showing a strong reversal signal. Moving averages are converging, suggesting a potential inflection point, but price action remains fragile. Current price 82.94 is just below S1 at 84.915 and above S2 at 75.633, so the stock is sitting near support, but not yet showing confirmed recovery. The modeled near-term trend is also soft, with expected declines over the next week and month.
["Rosenblatt reiterated Buy with a $250 target, arguing the selloff is a buying opportunity and that GPU shortages remain widespread.", "Cantor Fitzgerald sees CoreWeave on pace to materially beat backlog estimates and notes strong contract growth momentum.", "BNP Paribas initiated with Outperform and a $192 target, calling CoreWeave strategically important in AI infrastructure.", "Options sentiment is mildly bullish based on put-call ratios below 1.0.", "The stock is near support, which can sometimes attract dip buyers if sentiment stabilizes."]
["Meta's reported cloud plans are the main negative catalyst and directly pressure CoreWeave sentiment due to competition concerns and contract risk.", "Bernstein issued an Underperform with a $67 target, saying CoreWeave's model may become unsustainable as competition increases.", "The stock sold off sharply on the Meta headline, showing that the market is highly sensitive to competitive threats.", "Technical momentum is weak, with negative MACD expansion and no strong reversal confirmation.", "Stock trend modeling points to negative returns over the next week and month."]
No detailed financial snapshot was available, so a quarter-by-quarter financial read is limited. However, analyst commentary suggests strong recent operating momentum: Cantor Fitzgerald believes CoreWeave is on pace to nearly match about $40B of new contracts in 2Q26 and may already have secured around 90% of its 2027 $30B ARR target. That implies very strong backlog and revenue pipeline growth in the latest quarter season, even though profitability concerns remain a recurring issue.
Analyst sentiment is mixed but net constructive. Several firms are bullish: Rosenblatt Buy $250, BNP Paribas Outperform $192, Cantor Overweight $167, Citi Buy $158, and Deutsche Bank Buy $135. Countering that, Bernstein is bearish with Underperform and $67, and DA Davidson downgraded to Neutral with a $100 target, citing margin and debt concerns. Overall, Wall Street sees strong demand and strategic importance on the pro side, but worries about competition, profitability, and capital intensity on the con side. The recent trend in targets has been broadly supportive, though the Meta news has clearly reopened the competition debate.
